Mutants of a genetically well-characterized strain of Staphylococcus aureus [SA113(83A)] were isolated after mutagenization. Alpha-hemolysin-(hia), coagulase-(coa), and protein A-(spa) negative mutants were characterized by more than 90 biochemical tests for production of extracellular proteins and biochemical profile to exclude pleiotropy. Protoplast fusion was then used to isolate double-defective (hla and coa) recombinants and recombinants with regained properties, i.e., production of alpha-hemolysin and coagulase. Studies of such mutants and recombinants in the mouse mastitis model showed that one alpha-hemolysin 1SA113(83A) hla-5] and one coagulase-negative [SA113(83A) coa-147] mutant were lower in virulence compared with the wild-type strain SA113(83A). The double-negative mutant SA113(83A) hla-5 coa-147 showed a drastic decline in virulence and only induced very mild changes, as determined by microscopic examinations of infected mammary gland tissue. The recombinant with regained properties, however, was as virulent as the wild-type strain. This suggests that alpha-hemolysin and coagulase are virulence determinants of S. aureus. A high-level protein A-producing mutant (U300) showed the same virulence as the parent strain SA113(83A) in this model. One low virulence protein A-negative mutant (U320) did not markedly increase in virulence when a plasmid containing the cloned gene for protein A (pSPA15) was introduced into this mutant. By these and earlier observations, it seems likely that protein A is not an important virulence determinant in mastitis of mice. The reduced virulence of the protein A-negative mutant U320 compared with the wild-type SA113(83A) may be due to pleiotropic loss of some other unknown virulence determinant(s). Our data confirm earlier findings that pleiotropic changes are common in protein A-negative mutants.
Staphylococcus aureus produces many extracellular products which are considered as possible virulence factors (6) . In earlier reports the wild type and mutants of S. aureus SA113(83A), deficient in single probable virulence determinants, have been compared with different experimental infections (11, 16) . The response of mice to infection with staphylococci varies tremendously with the route of infection (10) . We have found earlier that the mouse mastitis model is a convenient, sensitive, and reproducible model for comparing the virulence of different mutants and the parental strain (11, 16) .
In this report our genetic approach to the evaluation of the virulence determinants of S. aureus is extended to include a comparison between mutants deficient in the production of alpha-hemolysin or coagulase and the wild-type or doubledeficient recombinants which were obtained after fusion and regeneration of protoplasts of the single mutants. To assess the significance of protein A as a virulence determinant, we tested a protein A-negative mutant in the mouse mastitis model and also tested the virulence of this mutant carrying the cloned protein A gene on a plasmid, which results in high production of protein A (24) . The advantage of this system is that the genetic background of the two strains is identical except for the presence of the plasmid in the transformant. * Corresponding author.
MATERIALS AND METHODS
Bacterial strains. The strains used in virulence experiments are listed in Table 1. The derivation of the different strains is sumnmarized in Fig. 1 . S. aureus SA113, a restriction-deficient mutant of strain 8325 (14) originally obtained from S. Iordanescu, was lysogenized with phage 83A and used for the isolation of mutants defective in potential virulence characters. Alphahemolysin (hla-5)-and coagulase (coa-147)-defective mutants were isolated after mutagenization with N-methyl-N'-nitro-N-nitrosoguanidine as previously described (16) . From the single mutants, double-defective (hla-5, coa-147) and wild-type recombinants were made by polyethylene glycolinduced fusion of protoplasts and regeneration of cell walls using the antibiotic resistance plasmids pC194 and jillde as fusion markers as described by Gotz et al. (9) . The recombinants and the parental segregants were cured of plasmids by the protoplasting procedure described by Novick et al. (19) , and after careful biochemical characterization they were used in virulence experiments.
In an earlier study protein A-deficient mutants of strain SA113(83A) were isolated and characterized (15) . The gene for protein A has been cloned in plasmid pBR322 and then recloned in plasmid pHV33 which replicates in both Escherichia coli and S. aureus (24) . The plasmid pHV33 which has the complete structural gene for protein A is called pSPA15. The transformation of pSPA15 into the protein A-negative mutant U320 has been described by Uhlen et al. (24) .
The different mutants and recombinants were tested for production of various extracellular proteins (toxins and enzymes), and the biochemical profiles were further defined with commercial test kit systems (API 20, API 50E, and API Zym; Analytab Products, La Balme les Grottes, France) (16) . All bacterial strains were stored in liquid nitrogen at -196°C (16) .
Media. Culture media such as DM3 agar and Trypticase soy agar (TSA; BBL Microbiology Systems) plates, used in experiments of genetic recombination by protoplast fusion as shown in Fig. 1 , have been described by Gotz et al. (9) .
Assay for hemolysins. Alpha-hemolysin production was detected on rabbit blood agar plates (5% [vol/vol] ). Each strain was also cross-streaked on rabbit blood agar plates with a central filter paper strip containing 0.1 ml of high-titer rabbit anti-alpha toxin (batch no. K 4031; Wellcome Research Laboratories, Beckenham, England). Beta-hemolysin was tested by culturing strains on blood agar containing sheep erythrocytes (5% [vol/vol] ) at 37°C followed by incubation at 4°C (hot-cold lysis) (3). None of the tested strains gave hot-cold lysis.
Assay of coagulase. Coagulase was determined with supernatants from overnight cultures in tubes with fresh citrated rabbit plasma diluted 1:3 in sterile saline (23) . The tests were read after 2 and 24 h at 37°C.
Assay of protein A. The protein A production was measured by an enzyme-linked immunosorbent assay after complete lysis of the cells by treatment with lysostaphin (17) .
Mouse mastitis model. The mouse mastitis model was used as described by Chandler (5) and Anderson (1) with minor modifications (11) . The mammary glands of groups of five mice were inoculated with bacteria suspended in peptone water medium. Pure peptone water was inoculated as controls. In the mouse mastitis model macroscopic and microscopic investigations of the mammary glands were evaluated as described in an earlier report (11) . The macroscopic lesions were classified as follows: gross +++), mediumgrade (+ +), low grade (+), and no changes (0). The histopathologic investigations were scored as (1) nonreactive total necrosis (Al); (2) initially reactive total necrosis (A2); (3) advanced regressive changes combined with mild inflammatory reaction, intermediate type (B); (4) disseminated inflammatory reaction combined with focal necrosis (Cl); (5) disseminated inflammatory reaction (C2); (6) focally distributed inflammatory reaction (C3); and (7) no reaction (0) (11) .
Statistical evaluation. The histopathologic investigations showed a wide range of pathological changes. There were less distinct borders between the different types of lesions than was noticed when the mammary glands were classified after macroscopic investigation. In the latter it was easier to evaluate the severity of the lesions. The data of the gross examination were used for statistical calculations since the results from the macroscopic and microscopic investigations agreed. Chi-square analysis was used for the evaluation of test results (2) . RESULTS Virulence of recombinants in relation to parental segregants and wild type. results we decided to compare the virulence of the protein A-negative mutant U320 (low virulence in earlier tests) with that of the same strain containing plasmid pSPA15 which carries the cloned gene for protein A. Both these strains were still significantly less virulent than the parent strain U300 (P < 0.0005). Furthermore there was no significant difference in virulence between strains U320 and U320(pSPA15) based on macroscopic examination (Table 3) . DISCUSSION S. aureus is a bacterial pathogen in a variety of infectious diseases in both humans and animals. Many extracellular proteins and toxins are produced which probably contribute to the virulence of this organism, but the exact role of the potential virulence determinants in different types of infections remains unclear.
In an earlier report (11) the virulence properties of wildtype, alpha-hemolysin, coagulase, and protein A-negative mutants have been compared after inoculation of the mammary glands of mice. Alpha-hemolysin-and coagulasenegative mutants showed decreased virulence compared with the wild-type strain, whereas different protein Anegative mutants differed considerably in virulence. Also Hasegawa and San Clemente (12) and, recently, Masuda (18) have shown that coagulase-negative mutants were significantly less virulent than the parent strain when tested in mice.
Mutagenization by treatment with chemical agents such as N-methyl-N'-nitro-N-nitrosoguanidine, which was used in this study, is risky. The simultaneous loss of several exoproteins on mutagenization of S. aureus has been noted by many investigators. There are so far no real explanations for the pleiotrophy, but several authors have suggested common regulatory mechanisms for the synthesis of various exoproteins in S. aureus, mainly based on the isolation of pleiotropic exoprotein-negative mutants (4, 7, 24) . Since we were aware of these problems all isolated mutants carefully characterized by more than 90 tests for determination of extracellular proteins and biochemical properties to exclude pleiotrophy (16) .
In the present study we wanted to investigate the effect of virulence in strains which had lost both alpha-hemolysin and coagulase in comparison with mutants defective in the respective single characters. To avoid a second mutagenization we applied the protoplast fusion method, as described by Gotz et al. (9) , which allowed the isolation of doubledefective and wild-type recombinants. Genetic recombination by protoplast fusion has been described in several bacterial systems, as reviewed by Hopwood (13). Stahl and Pattee (22) recently used protoplast fusion for chromosome mapping in S. aureus, and with the aid of a computer program they managed to combine the new recombination data and previously established linkage groups into a circular chromosome. In our fusions, antibiotic resistance plasmids were used as fusion markers. After isolation and characterization of segregants, the protoplasting procedure was repeated twice to cure for the plasmids (9). One coagulasenegative and one alpha-hemolysin-negative segregant were used in the virulence tests and compared with wild-type and double-deficient recombinants and the original wild-type strain SA113(83A) 
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The data presented in Table 2 confirm our earlier results that the loss of alpha-hemolysin or coagulase gives a reduced virulence in the mammary glands of mice. The loss of both determinants results in an additive decline in virulence which, in the wild-type recombinant, is fully restored to the level of the original wild-type strain. These data suggest that alpha-hemolysin and coagulase are important virulence factors in the mammary glands of mice.
During the last 2 years several of the genes coding for potential virulence determinants in S. aureus such as protein A (17), alpha-hemolysin (8), staphylokinase (20) , and nuclease (21) have been cloned in different plasmid vectors. It will now be possible to introduce specific mutations into the isolated genes by in vitro mutagenesis, and then the mutated genes can be transformed back into wild-type strains of S. aureus either by using plasmid vectors or by homologous recombination after transformation with linear DNA. Thus, there are now.increased possibilities to dissect the pathogenesis of S. aureus by studying virulence of such mutants in different animal models.
